Bio-Rad Labs (BIO) Reports Q4 EPS of $1.34
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $373.70 -0.87%
Revenue Growth %: -0.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $1.34, may not compare to the analyst estimate of $1.18. Revenue for the quarter came in at $598.2 million versus the consensus estimate of $593.41 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle reports earnings today: AI spending bet faces its toughest test yet
- Wynn Resorts plans $900M senior notes offering due 2035
- UBS Reiterates Neutral Rating on Yeti Holdings Inc. (YETI) Ahead of Analyst Meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
